Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

15307-79-6 - Diclofenac sodium salt - 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium salt - Sodium 2-(2,6-dichloroanilino)phenylacetate - J62609 - Alfa Aesar

J62609 Diclofenac sodium salt

CAS-Nummer
15307-79-6
Synonyme
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium salt
Sodium 2-(2,6-dichloroanilino)phenylacetate

Größe Preis ($) Menge Verfügbarkeit
5g 19,57
25g 44,29
100g 154,50
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Diclofenac sodium salt

MDL
MFCD00082251
EINECS
239-346-4

Chemische Eigenschaften

Formel
C14H10Cl2NNaO2
Molmasse
318.14
Form
Powder
Schmelzpunkt
283-285°
Löslichkeit
Soluble in water to 50mg/ml.

Anwendungen

Oxidation of diclofenac sodium produces the metabolite 4'-hydroxy diclofenac) which demonstrates specific inhibition of Cox-2. Inhibition of Cox by diclofenac and 4'-hydroxy diclofenac suppresses prostaglandin E2 synthesis, producing anti-inflammatory and analgesic effects. Diclofenac is also shown to stabilize the native tetrameric conformation of transthyretin (TTR) fibrils, preventing the formation of insoluble amyloidogenic TTR deposits. Diclofenac Sodium is a substrate of CYP2C9. It is also used as an inhibitor of Cox-1 and Cox-2.

Bemerkungen

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Keep away from strong oxidizing agents.

Literaturverweise

Barnett, J., et al. Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim. Biophys. Acta. 1994, 1209, (1), 130-9.

Laneuville, O., et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 1994, 271, (2), 927-34.

GHS Gefahren- und Sicherheitshinweise

Gefahrenhinweise (EU): H301-H361

Toxic if swallowed. Suspected of damaging fertility or the unborn child.

Sicherheitshinweise: P201-P281-P264-P270-P301+P310-P308+P313-P321-P330-P405-P501a

Obtain special instructions before use. Use personal protective equipment as required. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. IF exposed or concerned: Get medical advice/attention. Specific treatment (see label). Rinse mouth. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Weitere Referenzen

Merck
14,3081
Gefahrenklasse
6.1
Verpackungsgruppe
III
Harmonized Tariff Code
2922.49
TSCA
No
RTECS
AG6330000

Empfohlen

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf